2026-10-07T04:07:03Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33368749 2026-09-29T19:13:33Z category_24184 category_24196 category_24136 category_24151 category_24160 category_24172 category_24169 category_24325 category_24328 category_24346 category_24337 category_24340 category_24343 category_25144 category_25147 category_25159 category_25165 category_25168 category_25258 category_25270 category_26491 category_26494 category_26512 category_26584 category_26587 category_26620 category_26608 category_26605 category_26650 category_26659 category_26671 category_26677 category_26683 category_26728 category_26785 category_26788 category_26860 item_type_12 month_year_09_2026

The Biogenic Replicator Platform: Universal, On‑Demand Biologic Therapeutics and Closed‑Loop Homeostatic Regulation Through Programmed Molecular Assembly, Transient Gut‑Microbiome Reprogramming, and Learned Cybernetic Control - Edition (v2.0) Robert Ledgister (24667252) Bioinformatic methods development Proteomics and metabolomics Analytical biochemistry Enzymes Proteomics and intermolecular interactions (excl. medical proteomics) Synthetic biology Structural biology (incl. macromolecular modelling) Biocatalysis and enzyme technology Bioprocessing, bioproduction and bioproducts Industrial biotechnology not elsewhere classified Industrial microbiology (incl. biofeedstocks) Industrial molecular engineering of nucleic acids and proteins Nanobiotechnology Inorganic materials (incl. nanomaterials) Macromolecular materials Polymerisation mechanisms Supramolecular chemistry Theory and design of materials Computational chemistry Theoretical and computational chemistry not elsewhere classified Digital electronic devices Digital processor architectures Photonic and electro-optical devices, sensors and systems (excl. communications) Bio-fluids Biomedical fluid mechanics Fluid mechanics and thermal engineering not elsewhere classified Microfluidics and nanofluidics Hydrodynamics and hydraulic engineering Additive manufacturing Industrial engineering Manufacturing processes and technologies (excl. textiles) Microtechnology Precision engineering Functional materials Micro- and nanosystems Molecular and organic electronics Other engineering not elsewhere classified biogenic replicator, molecular compiler; molecular assembly; cell‑free synthesis; peptide synthesis; DNA synthesis; chimeric molecules; GLP‑1; insulin; glucagon; peptide therapeutics; therapeutic peptides; hierarchical merge; hierarchical merge matrix; programmable assembly; programmable molecular assembly; sequence‑defined polymers; yield equation; logarithmic merge architecture; solid‑phase scaffolding; addressable carriers; nLock/pLock; wavelength‑selective optical decapping; optical decapping; DMD; microfluidics; PDMS; soft lithography; capillary stop valves; PWM loading; PWM serial loading; visual servo control; diffusion purification; valve‑gated diffusion purification; hydrogel purification; lyophilized cartridge; lyophilized monomer cartridge; swarm processing unit; RISC‑V; TypeOneBIS; platform‑as‑a‑service; prior art; defensive publication; civilisational resilience; food synthesis; nutritional food synthesis; disaster resilience; deep‑space biological autonomy; off‑world molecular manufacturing; Replicator Foundation; community license; TypeOneBIS Community License; phage therapy; phage‑mediated gut microbiome reprogramming; gut microbiome; transient reprogramming; homeostatic regulation; closed‑loop control; closed‑loop homeostasis; biogenic regulator; implantable device; humanitarian access; freedom to operate, deterministic fluidics, ntegrated optical routing, optical waveguide, PDMS waveguide, optical switching, pneumatically actuated optical switch, magnetic optical switch, MEMS optical switch, electrostatic optical switch, piezoelectric optical switch, electrostrictive optical, switch, thermal optical switch, fluidic‑pneumatic‑optical processor, programmable matter processor, microfluidic optical processor, CSV diode, disaster‑resilient biomanufacturing, molecular printing service, programmable matter, rectangular fiber bundle illumination, fiber optic illumination matrix, passive optical delivery, fiber bundle array, fiber ferrule alignment, fiber splitters, fiber combiners, multimode optical fiber, red/blue laser distribution, chamber‑scale optical addressing, integrated optical decapping, programmable optical switch matrix, pneumatic optical waveguide switch, magnetic optical waveguide switch, MEMS optical waveguide switch, electrostatic optical waveguide switch, piezoelectric optical waveguide switch, electrostrictive optical waveguide switch, thermal optical waveguide switch, three‑layer optical waveguide, PDMS optical core, air‑cladding waveguide, glass‑air boundary reflection, edge‑coupled optical input, fiber‑to‑chip coupling, rack‑scale optical distribution, solid‑state optical switching, optical processor chip, fiber‑bundle chip interface, passive optical chip, fixed fiber array, chip‑integrated optics. single capillary stop valve diode, single-diode merge, two-input merge diode, shared CSV pocket, shared merge chamber, top-entry CSV diode, side-entry merge diode, multi-input capillary stop valve, synchronised meniscus burst, synchronised pressure release, threshold-gated release, threshold-gated merge, binary threshold diode, binary CSV operation, sub-threshold holding pressure, maximum burst pressure threshold, precharged pressure release, pressure ramping method, pinned meniscus release, simultaneous meniscus release, deterministic merge timing, zero-one valve operation, passive threshold gate, single-diode merge geometry, arbitrary input orientation, shared pocket aspect ratio, capillary stop valve runway, tapered merge output, expansion corner pinning, merge chamber empty state, fluid parking at diode entrance. AbstractThis upgraded edition (v2.0) of the white paper presents the biogenic replicator, a desktop and implantable molecular compiler that converts digital sequence files directly into therapeutic biologics without fermentation or cold chain. A “Plain‑Language Reader’s Guide: Is the Replicator Buildable?” has been added at the beginning of the document. It clarifies that all component technologies are mature—PDMS soft lithography (1980s), capillary stop valves (1990s), solid‑phase scaffolding (1970s), photocleavable groups (1970s), enzymatic cleavage (1980s–1990s), and pneumatic Quake valves (2000s)—and that the key novel element is the hierarchical merge matrix, a breakthrough solution to the yield equation Y = P ^ n. The guide also states that the merge matrix assembles a uniform carrier scaffold, with the final peptide/protein released only in the cleavage chamber.The platform’s first demonstration target is human GLP‑1 (glucagon‑like peptide‑1), a blockbuster metabolic hormone that is structurally simpler to produce than insulin yet commands a dominant global market position. Insulin, glucagon, and all other peptide and protein therapeutics can also be synthesised on the same hardware, enabling a universal, on‑demand biologic manufacturing system.The document discloses the complete system architecture, including the hierarchical merge network, pulse‑width modulated (PWM) serial loading with bidirectional differential pressure alignment and AI‑assisted visual feedback, a segmented parallel input matrix with moulded landing pads, valve‑gated pressure‑balanced diffusion purification, a lyophilized monomer cartridge with electrically addressable cylinder banks, phage‑mediated transient gut‑microbiome reprogramming, and an implantable closed‑loop homeostatic regulator. It also introduces critical new disclosures on civilisational resilience, nutritional food synthesis, and deep‑space biological autonomy (Section 11), and establishes the Replicator Foundation and the TypeOneBIS Community License (TCL) (Section 12) as a permanent governance and access framework. Prior art is established for non‑expiring disaster stockpiling, on‑demand production of nutritionally complete proteins and complex carbohydrates from ambient‑temperature‑stable monomers, and the biological sustainability architecture for permanent deep‑space missions. The scaffolding‑cleavage language has been elevated to a functional‑genus formulation covering any site‑specific catalytic mechanism. Throughput calculations and SPU core counts have been clarified, and the Foundation governance architecture—including phased delegation, anti‑capture provisions, Governance Challenge Right, and Mission Alignment Tribunal—is fully described and cross‑referenced to the TCL.All other sections remain unchanged from the original June 2026 publication. As before, this document is published to establish prior art and ensure unrestricted freedom of operation for TypeOneBIS and the global community. No element described herein may be patented by any other party.Keywords: biogenic replicator, molecular compiler; molecular assembly; cell‑free synthesis; peptide synthesis; DNA synthesis; chimeric molecules; GLP‑1; insulin; glucagon; peptide therapeutics; therapeutic peptides; hierarchical merge; hierarchical merge matrix; programmable assembly; programmable molecular assembly; sequence‑defined polymers; yield equation; logarithmic merge architecture; solid‑phase scaffolding; addressable carriers; nLock/pLock; wavelength‑selective optical decapping; optical decapping; DMD; microfluidics; PDMS; soft lithography; capillary stop valves; PWM loading; PWM serial loading; visual servo control; diffusion purification; valve‑gated diffusion purification; hydrogel purification; lyophilized cartridge; lyophilized monomer cartridge; swarm processing unit; RISC‑V; TypeOneBIS; platform‑as‑a‑service; prior art; defensive publication; civilisational resilience; food synthesis; nutritional food synthesis; disaster resilience; deep‑space biological autonomy; off‑world molecular manufacturing; Replicator Foundation; community license; TypeOneBIS Community License; phage therapy; phage‑mediated gut microbiome reprogramming; gut microbiome; transient reprogramming; homeostatic regulation; closed‑loop control; closed‑loop homeostasis; biogenic regulator; implantable device; humanitarian access; freedom to operate, deterministic fluidics, integrated optical routing, optical waveguide, PDMS waveguide, optical switching, pneumatically actuated optical switch, magnetic optical switch, MEMS optical switch, electrostatic optical switch, piezoelectric optical switch, electrostrictive optical, switch, thermal optical switch, fluidic‑pneumatic‑optical processor, programmable matter processor, microfluidic optical processor, CSV diode, disaster‑resilient biomanufacturing, molecular printing service, programmable matter, rectangular fiber bundle illumination, fiber optic illumination matrix, passive optical delivery, fiber bundle array, fiber ferrule alignment, fiber splitters, fiber combiners, multimode optical fiber, red/blue laser distribution, chamber‑scale optical addressing, integrated optical decapping, programmable optical switch matrix, pneumatic optical waveguide switch, magnetic optical waveguide switch, MEMS optical waveguide switch, electrostatic optical waveguide switch, piezoelectric optical waveguide switch, electrostrictive optical waveguide switch, thermal optical waveguide switch, three‑layer optical waveguide, PDMS optical core, air‑cladding waveguide, glass‑air boundary reflection, edge‑coupled optical input, fiber‑to‑chip coupling, rack‑scale optical distribution, solid‑state optical switching, optical processor chip, fiber‑bundle chip interface, passive optical chip, fixed fiber array, chip‑integrated optics. Related Identifiers:<ul><li>Is supplemented by: Patent Application No. a/0002/000329 (filed 27 May 2026)</li><li>TypeOneBIS Community License : <a href="https://doi.org/10.5281/zenodo.20586399" target="_blank" rel="noreferrer">https://doi.org/10.5281/zenodo.20586399</a></li><li>TypeOneBIS Community License : <a href="https://doi.org/10.6084/m9.figshare.33408301" target="_blank" rel="noreferrer">https://doi.org/10.6084/m9.figshare.33408301</a></li><li>GDSII and OASIS dataset for the 2-mer and 16-mer chips : <a href="https://doi.org/10.5281/zenodo.22881132" target="_blank">https://doi.org/10.5281/zenodo.22881132</a></li><li>GDSII and OASIS dataset for the 2-mer and 16-mer chips : <a href="https://doi.org/10.6084/m9.figshare.34027272" target="_blank">https://doi.org/10.6084/m9.figshare.34027272</a></li></ul>Affiliation: TypeOneBIS:Publication Date: June 02, 2026 (original); upgraded edition [September 29, 2026]Email: replicator@typeonebis.comLicense: Creative Commons Attribution‑NonCommercial 4.0 International (CC BY‑NC 4.0) Language: English Sites Published: <a href="https://doi.org/10.5281/zenodo.22215794" target="_blank" rel="noreferrer">Zenodo</a> Notes: This white paper is a defensive publication. All technical details, safety interfaces, consumable longevity calculations, redundancy architectures, and implementation variants are explicitly placed into the public domain to establish prior art. No element described herein may be patented by any other party. Patent pending (Application No. a/0002/000329, filed 27 May 2026); PCT application to be filed claiming priority from that date. Version 1.8 – Update NotesAdded Sections1. Single Capillary Stop Valve Diode for Two-Input Merge OperationsThis new subsection under Part A: General Platform Architecture discloses the use of a single shared capillary stop valve pocket as the merge element for two or more fluidic inputs.The disclosure explicitly covers:<ul><li>input entry from any side or combination of sides,</li><li>arbitrary chamber aspect ratio,</li><li>arbitrary pocket geometry,</li><li>any taper angle or contraction shape,</li><li>any channel dimensions,</li><li>and any corner sharpness capable of pinning a meniscus.</li></ul>The core principle protected is the use of one shared CSV diode for the merge operation, regardless of geometry.2. Binary Threshold Operation of the Capillary Stop Valve DiodeThis new subsection describes the threshold-gated, synchronised release method:<ul><li>fluid is driven into the system under sub-threshold pressure;</li><li>each meniscus pins at its respective sharp 90° entrance;</li><li>the merge chamber remains empty until the release event;</li><li>the external pressure source is ramped to or above the highest burst threshold among all pinned menisci;</li><li>only then is the pressure admitted to the diode;</li><li>all menisci release simultaneously in a digital, binary fashion.</li></ul>This disclosure establishes prior art for synchronised threshold operation in any single-diode merge chamber.3. Comprehensive Scope of DisclosureA combined scope statement has been added after the two new subsections. It enumerates, without limitation, the parameters that may be varied without departing from the protected principle, including:<ul><li>number of inputs,</li><li>input orientation,</li><li>chamber geometry and aspect ratio,</li><li>taper shape and angle,</li><li>channel dimensions,</li><li>corner sharpness,</li><li>pressure application and ramping methods,</li><li>gating valve types,</li><li>calibration methods,</li><li>and operating sequences.</li></ul>The scope statement confirms that the fundamental principle is the single diode as a threshold-controlled merge element, with synchronised binary release. Version 2.0 – Update Notes<h3 dir="ltr">Reason</h3>This upgraded edition (v2.0) of the white paper records the transition of the TypeOneBIS Biogenic Replicator platform from theory to physical chip prototype. The reference designs have been completed as OASIS and GDSII mask layouts, and fabrication of the first prototype is underway at a premier interdisciplinary institute.The reference design files (OASIS and GDSII) are published as a separate dataset under the TypeOneBIS Community License found at Concept DOI : <a href="https://doi.org/10.5281/zenodo.20586399" target="_blank"><code>https://doi.org/10.5281/zenodo.20586399</code></a>The published GDSII and OASIS dataset for the 2-mer baseline chip and the 16-mer industrial chip can be found at Concept DOI : <a href="https://doi.org/10.5281/zenodo.22881132" target="_blank">https://doi.org/10.5281/zenodo.22881132</a> 2026-06-03T00:00:00Z Text Preprint 10.6084/m9.figshare.33368749.v4 https://figshare.com/articles/preprint/The_Biogenic_Replicator_Platform_Universal_On_Demand_Biologic_Therapeutics_and_Closed_Loop_Homeostatic_Regulation_Through_Programmed_Molecular_Assembly_Transient_Gut_Microbiome_Reprogramming_and_Learned_Cybernetic_Control_-_Edition_v1_7_/33368749 CC BY 4.0